Testing the Tests: COVID-19 Antibody Assays Scrutinized for Accuracy by UCSF, UC Berkeley Researchers
A project launched by UC San Francisco and UC Berkeley scientists evaluated some of the more than 120 available antibody test kits.
University of California San Francisco
Give to UCSFA project launched by UC San Francisco and UC Berkeley scientists evaluated some of the more than 120 available antibody test kits.
BRIDGE is an interface available to physicians during their encounter with patients.
As people around the world try to envision recovery from the COVID-19 pandemic, much attention has been paid to antibody testing as a way to identify people who have developed immunity to the virus. UCSF experts explain how antibody testing works, who it can be most useful for and why we should be cautious.
A UCSF researcher is among the team that announced promising Phase 1 clinical results for the first new oral polio vaccine in 50 years.
Marilyn Stebbins, a UCSF School of Pharmacy faculty member, shares a firsthand account of being a COVID-19 patient.
The UCSF health care workers specialize in critical care, intensive care, acute care and hospital medicine.
UCSF infectious disease researchers and community partners have launched an effort to provide comprehensive, voluntary COVID-19 testing to all residents of two distinctive Bay Area communities.
UCSF researchers now have reported a new method to design and test cell therapies, one they expect will speed the development of new life-saving treatments not only for cancer, but for other diseases, too.